Details of the Drug

General Information of Drug (ID: DM30YQF)

Drug Name

(Z)-4-(4-hexylphenylamino)-4-oxobut-2-enoic acid

Synonyms

Substituted Acrylamide, 7b; CHEMBL235904; BDBM18847; (2Z)-3-[(4-hexylphenyl)carbamoyl]prop-2-enoic acid; (2z)-4-[(4-hexylphenyl)amino]-4-oxobut-2-enoic acid

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

275.34

Logarithm of the Partition Coefficient (xlogp)

3.8

Rotatable Bond Count (rotbonds)

8

Hydrogen Bond Donor Count (hbonddonor)

2

Hydrogen Bond Acceptor Count (hbondacc)

3

Chemical Identifiers

Formula: C16H21NO3
IUPAC Name: (Z)-4-(4-hexylanilino)-4-oxobut-2-enoic acid
Canonical SMILES: CCCCCCC1=CC=C(C=C1)NC(=O)/C=C\\C(=O)O
InChI: InChI=1S/C16H21NO3/c1-2-3-4-5-6-13-7-9-14(10-8-13)17-15(18)11-12-16(19)20/h7-12H,2-6H2,1H3,(H,17,18)(H,19,20)/b12-11-
InChIKey: OOWYMHDWBQTCOX-QXMHVHEDSA-N

Cross-matching ID

PubChem CID: 23635730
TTD ID: D0J0MD

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Thyroid hormone receptor alpha (THRA)	TTTSEPU	THA_HUMAN	Inhibitor	[1]
Thyroid hormone receptor beta (THRB)	TTGER3L	THB_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships. J Med Chem. 2007 Nov 1;50(22):5269-80.